Document is current
Any future updates will be listed below
-
Authors
Bloomfield, Doni
Teng, Theodore W.
Kesselheim, Aaron S.
Tu, S. Sean
-
Funding
Funding for this research was provided by:
Arnold Ventures
Commonwealth Fund
- License Information
-
More Information
Article History
Received: 9 January 2025
Accepted: 1 July 2025
First Online: 16 July 2025
Declarations:
:
: Not applicable.
: Dr. Tu reported consulting for purchasers of lenalidomide- and abiraterone acetate-containing products outside the submitted work. Dr. Kesselheim reports serving as an expert witness on behalf of patients against Gilead relating to its tenofovir-containing products and on behalf of payors against J&J related to introduction of biosimilar Stelara.
: The funders had no role in the design or conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
